198 related articles for article (PubMed ID: 18386000)
61. A dual-function DNA vaccine encoding carcinoembryonic antigen and CD40 ligand trimer induces T cell-mediated protective immunity against colon cancer in carcinoembryonic antigen-transgenic mice.
Xiang R; Primus FJ; Ruehlmann JM; Niethammer AG; Silletti S; Lode HN; Dolman CS; Gillies SD; Reisfeld RA
J Immunol; 2001 Oct; 167(8):4560-5. PubMed ID: 11591784
[TBL] [Abstract][Full Text] [Related]
62. Pretreatment with cisplatin enhances E7-specific CD8+ T-Cell-mediated antitumor immunity induced by DNA vaccination.
Tseng CW; Hung CF; Alvarez RD; Trimble C; Huh WK; Kim D; Chuang CM; Lin CT; Tsai YC; He L; Monie A; Wu TC
Clin Cancer Res; 2008 May; 14(10):3185-92. PubMed ID: 18483387
[TBL] [Abstract][Full Text] [Related]
63. Amplification of the lytic potential of effector/memory CD8+ cells by vector-based enhancement of ICAM-1 (CD54) in target cells: implications for intratumoral vaccine therapy.
Slavin-Chiorini DC; Catalfamo M; Kudo-Saito C; Hodge JW; Schlom J; Sabzevari H
Cancer Gene Ther; 2004 Oct; 11(10):665-80. PubMed ID: 15354200
[TBL] [Abstract][Full Text] [Related]
64. Combination therapy with dendritic cells and lenalidomide is an effective approach to enhance antitumor immunity in a mouse colon cancer model.
Vo MC; Nguyen-Pham TN; Lee HJ; Jaya Lakshmi T; Yang S; Jung SH; Kim HJ; Lee JJ
Oncotarget; 2017 Apr; 8(16):27252-27262. PubMed ID: 28460478
[TBL] [Abstract][Full Text] [Related]
65. Enhancement of therapeutic DNA vaccine potency by melatonin through inhibiting VEGF expression and induction of antitumor immunity mediated by CD8+ T cells.
Baghban Rahimi S; Mohebbi A; Vakilzadeh G; Biglari P; Razeghi Jahromi S; Mohebi SR; Shirian S; Gorji A; Ghaemi A
Arch Virol; 2018 Mar; 163(3):587-597. PubMed ID: 29149434
[TBL] [Abstract][Full Text] [Related]
66. T cell memory against colon carcinoma is long-lived in the absence of antigen.
Xiang R; Lode HN; Gillies SD; Reisfeld RA
J Immunol; 1999 Oct; 163(7):3676-83. PubMed ID: 10490962
[TBL] [Abstract][Full Text] [Related]
67. Are DNA-based vaccines useful for protection against secreted bacterial toxins? Tetanus toxin test case.
Saikh KU; Sesno J; Brandler P; Ulrich RG
Vaccine; 1998; 16(9-10):1029-38. PubMed ID: 9682355
[TBL] [Abstract][Full Text] [Related]
68. Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8+ T-cell response and inhibits the PSCA+ tumors growth in mice.
Zhang X; Yu C; Zhao J; Fu L; Yi S; Liu S; Yu T; Chen W
J Gene Med; 2007 Aug; 9(8):715-26. PubMed ID: 17595048
[TBL] [Abstract][Full Text] [Related]
69. Local administration of IL-12-transfected dendritic cells induces antitumor immune responses to colon adenocarcinoma in the liver in mice.
Satoh Y; Esche C; Gambotto A; Shurin GV; Yurkovetsky ZR; Robbins PD; Watkins SC; Todo S; Herberman RB; Lotze MT; Shurin MR
J Exp Ther Oncol; 2002; 2(6):337-49. PubMed ID: 12440225
[TBL] [Abstract][Full Text] [Related]
70. New strategies for vaccination and imunomodulation in NHL.
Stevenson FK; Zhu D; Rice J
Ann Hematol; 2001; 80 Suppl 3():B132-4. PubMed ID: 11757697
[TBL] [Abstract][Full Text] [Related]
71. External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing.
Chakraborty M; Abrams SI; Coleman CN; Camphausen K; Schlom J; Hodge JW
Cancer Res; 2004 Jun; 64(12):4328-37. PubMed ID: 15205348
[TBL] [Abstract][Full Text] [Related]
72. Humoral and cellular immunity induced by tumor cell vaccine based on the chicken xenogeneic homologous matrix metalloproteinase-2.
Yi T; Wei YQ; Tian L; Zhao X; Li J; Deng HX; Wen YJ; Zou CH; Tan GH; Kan B; Su JM; Jiang Y; Mao YQ; Chen P; Wang YS
Cancer Gene Ther; 2007 Feb; 14(2):158-64. PubMed ID: 17124509
[TBL] [Abstract][Full Text] [Related]
73. Fusion proteins of Hsp70 with tumor-associated antigen acting as a potent tumor vaccine and the C-terminal peptide-binding domain of Hsp70 being essential in inducing antigen-independent anti-tumor response in vivo.
Zhang H; Huang W
Cell Stress Chaperones; 2006; 11(3):216-26. PubMed ID: 17009594
[TBL] [Abstract][Full Text] [Related]
74. Regulatory T-cell depletion synergizes with gp96-mediated cellular responses and antitumor activity.
Yan X; Zhang X; Wang Y; Li X; Wang S; Zhao B; Li Y; Ju Y; Chen L; Liu W; Meng S
Cancer Immunol Immunother; 2011 Dec; 60(12):1763-74. PubMed ID: 21789592
[TBL] [Abstract][Full Text] [Related]
75. Peptide vaccination directed against IDO1-expressing immune cells elicits CD8
Dey S; Sutanto-Ward E; Kopp KL; DuHadaway J; Mondal A; Ghaban D; Lecoq I; Zocca MB; Merlo LMF; Mandik-Nayak L; Andersen MH; Pedersen AW; Muller AJ
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32690770
[TBL] [Abstract][Full Text] [Related]
76. Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer.
Kim S; Lee JB; Lee GK; Chang J
Prostate; 2009 Jun; 69(9):938-48. PubMed ID: 19267351
[TBL] [Abstract][Full Text] [Related]
77. Engineered DNA Vaccination against Follicle-Stimulating Hormone Receptor Delays Ovarian Cancer Progression in Animal Models.
Perales-Puchalt A; Wojtak K; Duperret EK; Yang X; Slager AM; Yan J; Muthumani K; Montaner LJ; Weiner DB
Mol Ther; 2019 Feb; 27(2):314-325. PubMed ID: 30554854
[TBL] [Abstract][Full Text] [Related]
78. Intratumoral DNA electroporation induces anti-tumor immunity and tumor regression.
Radkevich-Brown O; Piechocki MP; Back JB; Weise AM; Pilon-Thomas S; Wei WZ
Cancer Immunol Immunother; 2010 Mar; 59(3):409-17. PubMed ID: 19730859
[TBL] [Abstract][Full Text] [Related]
79. Targeting of MYCN by means of DNA vaccination is effective against neuroblastoma in mice.
Stermann A; Huebener N; Seidel D; Fest S; Eschenburg G; Stauder M; Schramm A; Eggert A; Lode HN
Cancer Immunol Immunother; 2015 Oct; 64(10):1215-27. PubMed ID: 26076666
[TBL] [Abstract][Full Text] [Related]
80. Targeting of the non-mutated tumor antigen HER2/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice.
Wang B; Zaidi N; He LZ; Zhang L; Kuroiwa JM; Keler T; Steinman RM
Breast Cancer Res; 2012 Mar; 14(2):R39. PubMed ID: 22397502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
